Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Momenta shares fall more than 24% on rival's FDA approval
Momenta shares fall more than 24% on rival's FDA approval
Momenta shares fall more than 24% on rival's FDA approval
Submitted by
admin
on September 19, 2011 - 6:01pm
Source:
Bizjournals.com
News Tags:
Momenta
FDA
Sanofi
Lovenox
Amphastar
Novartis
Sandoz
Headline:
Momenta shares fall more than 24% on rival's FDA approval
Do Not Allow Advertisers to Use My Personal information
